Stromal genes add prognostic information to proliferation and histoclinical markers: A basis for the next generation of breast cancer gene signatures

9Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

First-generation gene signatures that identify breast cancer patients at risk of recurrence are confined to estrogen-positive cases and are driven by genes involved in the cell cycle and proliferation. Previously we induced sets of stromal genes that are prognostic for both estrogen-positive and estrogen-negative samples. Creating risk-management tools that incorporate these stromal signatures, along with existing proliferation-based signatures and established clinicopathological measures such as lymph node status and tumor size, should better identify women at greatest risk for metastasis and death.

Cite

CITATION STYLE

APA

Mefford, D., & Mefford, J. (2012). Stromal genes add prognostic information to proliferation and histoclinical markers: A basis for the next generation of breast cancer gene signatures. PLoS ONE, 7(6). https://doi.org/10.1371/journal.pone.0037646

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free